Connect with us
DAPA Banner

Business

Intel Stock Soars 23% on Q1 Earnings Beat, AI Data Center Surge and Strong Outlook

Published

on

Executives at Silicon Valley chip maker Intel say 'fluid' US trade policies and regulatory moves have increased the chances of economic slowdown

SANTA CLARA, Calif. — Intel Corp. shares exploded higher by more than 22% in morning trading Friday, climbing to around $82.05 after the chipmaker delivered a blockbuster first-quarter earnings beat and raised its outlook, signaling accelerating momentum in its data center and AI business under CEO Lip-Bu Tan.

Executives at Silicon Valley chip maker Intel say 'fluid' US trade policies and regulatory moves have increased the chances of economic slowdown
Intel Stock Soars 23% on Q1 Earnings Beat, AI Data Center Surge and Strong Outlook
AFP

The stock (NASDAQ: INTC) opened sharply higher and sustained massive gains on April 24, with trading volume surging well above average. The move marks one of Intel’s largest single-day percentage gains in decades and pushes shares to levels not seen since the early 2000s tech boom, extending a remarkable recovery that has seen the stock more than double year-to-date.

Intel reported first-quarter revenue of $13.6 billion, a 7% increase from the year-ago period and well above Wall Street expectations of around $12.3 billion to $12.4 billion. Adjusted earnings per share came in at 29 cents, crushing consensus estimates of roughly 1 cent. The Data Center and AI segment drove much of the upside, generating $5.1 billion in revenue — up 22% year-over-year — as demand for Xeon processors in AI infrastructure outpaced supply.

CEO Lip-Bu Tan highlighted strong execution across the portfolio. “We are laser-focused on increasing output from our factories to meet demand,” he said on the earnings call. The company guided second-quarter revenue between $13.8 billion and $14.8 billion, topping analyst forecasts, and pointed to continued strength in AI server CPUs and foundry progress.

The results underscore Tan’s turnaround efforts since taking the helm. Intel has stabilized its foundry business, improved manufacturing yields on advanced nodes and secured key design wins. Partnerships with hyperscalers and announcements involving Tesla and Google have bolstered confidence in its ability to compete in the AI era.

Advertisement

Wall Street reacted with a wave of upgrades and price target increases. Several firms cited improved visibility into AI-driven growth and better operational execution. The stock’s forward valuation expanded, but analysts argued the premium is justified by multi-year growth potential in data centers and custom silicon.

Intel’s foundry segment showed signs of progress despite ongoing losses, with external customers contributing more meaningfully. The company continues investing heavily in U.S. manufacturing capacity, supported by CHIPS Act funding, as it positions itself as a viable alternative to TSMC for advanced process technology.

The surge comes amid broader semiconductor optimism. Peers like Texas Instruments also posted strong results recently, but Intel’s move stands out for its magnitude and the market’s renewed belief in its competitive positioning. The U.S. government, which holds a significant stake through prior investments, saw paper gains of billions on the rally.

Challenges persist. Intel still faces GAAP losses tied to restructuring and high capital expenditures. Competition from AMD, Nvidia and emerging players in AI accelerators remains intense. However, management struck an optimistic tone, emphasizing improved gross margins — non-GAAP at 41% — and demand that continues to outstrip supply in key areas.

Advertisement

Analysts now forecast stronger full-year performance, with some projecting mid-teens revenue growth if AI tailwinds persist. Consensus price targets have risen sharply, with several firms seeing upside to $100 or more if execution continues. The stock trades at elevated multiples but reflects expectations of a sustained recovery.

For investors, Friday’s pop highlights the power of earnings beats in a market rewarding AI exposure. Intel, long viewed as a turnaround story with execution risks, has delivered six straight quarters of beating estimates, rebuilding credibility and momentum.

As trading continued Friday morning, INTC shares held strong gains while broader markets showed mixed sentiment amid geopolitical developments. The move caps a dramatic short-term run and positions Intel as one of the top-performing large-cap chip stocks of 2026 so far.

Longer term, success will hinge on scaling advanced manufacturing, winning more external foundry customers and capitalizing on the shift toward CPUs in certain AI workloads. With a fortified balance sheet and renewed investor enthusiasm, Intel appears at a potential inflection point after years of challenges.

Advertisement

The impressive reaction underscores Wall Street’s appetite for concrete progress in the AI supply chain. Whether this momentum sustains will depend on consistent delivery in coming quarters, but for now, Intel is riding a powerful wave of optimism fueled by strong demand and strategic execution.

Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

4 ways to shore up South Asian coastal communities against climate change

Published

on

4 ways to shore up South Asian coastal communities against climate change

Marginalized South Asian communities, particularly coastal dwellers in Pakistan, the Maldives, and Bangladesh’s GBM delta, face critical climate change risks. Rising sea levels and extreme weather events like Pakistan’s monsoon floods threaten livelihoods and homes, forcing displacement and profession changes.

Key Challenges

  • High vulnerability: Coastal communities in Pakistan, Bangladesh, and the Maldives face severe risks from flooding and rising sea levels.
  • Pakistan: Monster monsoons and rising seas have displaced millions, forcing farmers to switch to fishing.
  • Bangladesh: The Ganges-Brahmaputra-Meghna delta and Sundarbans mangrove forest are under threat, with Dhaka absorbing thousands of climate refugees daily.
  • Maldives: Rising seas could make the island nation disappear by 2100.

South Asian coastal communities are disappearing at alarming rates due to climate change. Solutions require a mix of nature-based restoration, resilient infrastructure, planned relocation, and innovative engineering to safeguard livelihoods and cultures.

The Maldives, an archipelago nation, is at risk of disappearing entirely. Solutions include mangrove restoration for coastal protection, building raised homes to mitigate floods, relocating communities to climate-resilient cities, and constructing artificial islands like Hulhumalé in the Maldives. These adaptations are vital to protect vulnerable populations from an existential threat.

Source link

Advertisement
Continue Reading

Business

Justice Department drops criminal probe of Fed chair Powell, likely clearing way for Warsh

Published

on

Justice Department drops criminal probe of Fed chair Powell, likely clearing way for Warsh
The Justice Department has ended its probe into Federal Reserve chair Jerome Powell, clearing a major roadblock to the confirmation of his successor, Kevin Warsh.

U.S. Attorney for the District of Columbia Jeannine Pirro said on X on Friday that her office was ending its probe into the Fed’s extensive building renovations because the Fed’s inspector general would scrutinize them instead.

The move could lead to a swift confirmation vote by the Senate for Warsh, a former top Fed official whom President Donald Trump, a Republican, nominated in January to replace Powell. Powell’s term as chair ends May 15. Sen. Thom Tillis, a North Carolina Republican, had said he would oppose Warsh until the investigation was resolved, effectively blocking his confirmation.

With the investigation completed, the leadership transition at the world’s leading central bank may proceed quickly. Republicans praised Warsh during a Tuesday hearing even as Democrats questioned his independence from Trump, the lack of transparency around some of his financial holdings, and what they said was his flip-flopping on interest rates. Still, Trump’s previous appointment to the Fed’s board of governors, Stephen Miran, was approved by the full Senate just 13 days after his nomination.

Advertisement

The investigation was among several undertaken by the Justice Department into Trump’s perceived adversaries. For months it had failed to gain traction as prosecutors struggled to articulate a basis to suspect criminal conduct.


A prosecutor handling the case conceded at a closed-door court hearing in March that the government hadn’t yet found any evidence of a crime, and a judge subsequently quashed subpoenas issued to the Federal Reserve. The judge, James Boasberg, said prosecutors had produced “essentially zero evidence” to suspect Powell of a crime. Boasberg branded prosecutors’ justification for the subpoenas as “thin and unsubstantiated.”
More recently, prosecutors made an unannounced visit to a construction site at the Fed’s headquarters but were turned away, drawing a rebuke from a defense attorney in the case who called the maneuver “not appropriate.”Warsh said during the Senate hearing Tuesday that he never promised the White House that he would cut interest rates, even as the president renewed his calls for the central bank to do so.

“The president never once asked me to commit to any particular interest rate decision, period,” Kevin Warsh, a former top Fed official, said under questioning by the Senate Banking Committee. “Nor would I ever agree to do so if he had. … I will be an independent actor if confirmed as chair of the Federal Reserve.”

Warsh’s comments came just hours after Trump, in an interview on CNBC, was asked if he would be disappointed if Warsh didn’t immediately cut rates and responded, “I would.”

The decision to abandon the investigation represents a rare pullback for a Justice Department that over the last year has moved aggressively, albeit unsuccessfully, to prosecute public figures the president does not like.

Advertisement

Robert Hur, an attorney for the Federal Reserve Board of Governors, didn’t immediately respond Friday to an email seeking comment.

Continue Reading

Business

Firefly Aerospace: Future Looks More Certain Than Before (NASDAQ:FLY)

Published

on

Firefly Aerospace: Future Looks More Certain Than Before (NASDAQ:FLY)

This article was written by

I write about stocks I’m personally interested in adding to my portfolio. I’m not a professional advisor, but I study business and economics and analyze markets full-time. My writing is meant for both complete beginners — I avoid unnecessary complexity — and advanced readers, as I always aim to offer a distinct and well-reasoned perspective.I also run a YouTube Channel called “The Market Monkeys” and break some of the stocks there as well.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Business

FDA fast-tracks psychedelic drug research following Trump order

Published

on

FDA reversals on UniQure, Moderna approvals worry investors

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency in Washington, May 7, 2019.

DEA | Reuters

The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness.

Advertisement

That comes after President Donald Trump signed an executive order on Saturday directing federal health agencies to expand access to emerging therapies.

The move marks a significant shift toward supporting psychedelic-based medicines for conditions such as treatment-resistant depression, post-traumatic stress disorder and other substance use disorders, the FDA said.

“Under President Trump’s leadership, we are accelerating the research, approval and responsible access to promising mental health treatments,” Robert F. Kennedy Jr., secretary of the U.S. Department of Health and Human Services, said in the release. “The FDA will prioritize therapies with Breakthrough Therapy designation, where early evidence shows meaningful improvement.”

As part of the announcement, the FDA said it would issue national priority vouchers to companies studying psilocybin for depression and methylone for PTSD.

Advertisement

The agency also cleared an early-stage clinical trial for noribogaine hydrochloride, a derivative of ibogaine, as a potential treatment for alcohol use disorder. This is the first time a compound like it has been authorized for study in the U.S. and for human trial.

“These medications have the potential to address the nation’s mental health crisis,” FDA Commissioner Marty Makary said in the announcement. “It is critical that their development is grounded in sound science and rigorous clinical evidence.”

The FDA said allowing these studies to proceed does not mean the drugs are approved or proven safe and effective. Officials said data with be closely monitored as research advances.

“If they are approved, they will be approved with certain conditions. These are not the medications you get a prescription for and pick up at a pharmacy,” Makary told CNBC.

Advertisement

Makary went on to say decisions on some of these therapies could come as soon as this summer or fall.

The fast turnaround time for drug approvals has been a priority for the Trump administration, which dropped the decades-old standard of requiring two clinical trials for standard drug reviews earlier this year. The new policies have come with some criticism, as industry experts have warned about potential issues with a faster timetable.

With Friday’s psychedelic announcement, the Trump administration also said pricing remains an important consideration in fast-tracking trials.

“We have very openly said that affordability is an important part of a medication’s effectiveness on a population level,” Makary said. “Lowering drug prices is one of the top priorities in this administration, and it’s something we think about in every decision, including how we prioritize the vouchers.”

Advertisement

The announcement also follows the Trump administration saying it would ease restrictions on state-licensed medical cannabis operators.

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.
Continue Reading

Business

Primis Financial Corp. (FRST) Q1 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Operator

Ladies and gentlemen, thank you for standing by. My name is Colby, and I’ll be your conference operator today. At this time, I would like to welcome you to the Primis Financial Corp. First Quarter Earnings Call. [Operator Instructions]

I will now turn the call over to Matthew Switzer. You may begin.

Advertisement

Matthew Switzer
Executive VP & CFO

Good morning, and thank you for joining us for Primis Financial Corp.’s 2026 First Quarter Webcast and Conference Call.

Before we begin, please note that many of our comments during this call will be forward-looking statements, which involve risk and uncertainty. There are many factors that could cause actual results to differ materially from the anticipated results or other expectations expressed in the forward-looking statements.

Further discussion of the company’s risk factors and other important information regarding our forward-looking statements are part of our recent filings with the Securities and Exchange Commission, including our recently filed earnings release, which has also been posted to the Investor Relations section of our corporate site, primisbank.com. We undertake no obligation to update or revise forward-looking statements to reflect changes in assumptions, the occurrence of unanticipated events or changes to future operating results over time.

Advertisement

In addition, some of the financial measures that we may discuss this morning are non-GAAP financial measures. How a non-GAAP measure relates to the most comparable GAAP measure will be discussed when the non-GAAP measures used, if not readily apparent.

I

Advertisement
Continue Reading

Business

How Much Should Companies Spend on Branded Gifts?

Published

on

Branded t shirt

This is a question that tends to induce bouts of anxiety and even fierce debate between different departments within the business. Without question, branded gifts have a value beyond their actual cost and they are a great way of getting your brand in front of people, but how much should you spend to achieve this aim?

It’s not easy to give a definitive answer about how much to spend on branded gifts. This is because every business will have a different size of budget in mind, and even a different mindset about what represents good value for money.

Certain branded gifts, such as mugs with logo, are often cost-effective solutions as you won’t have to spend huge sums of your marketing budget to see a positive return on your investment. To get a bit of clarity on the subject, here’s some key points to consider.

Understand why you are spending the money

A good starting point would be to appreciate why you are spending money on branded gifts and what you want to achieve from your investment in this proven marketing tool.

Ultimately, you are looking to try and build strong relationships with your customers and keep your name in their mindset when they are making purchasing decisions. Corporate gifts are a great way of achieving those aims as they help encourage a sense of loyalty and appreciation.

Advertisement

When you give someone a branded gift it helps them to feel valued. Even a relatively modest outlay on something like branded mugs or pens can really help strengthen that bond. How do you quantify that sort of response to your gift?

Instead of looking at the pure cost of a branded gift that you are going to use to promote your business it’s wise to also make an allowance for the benefits it delivers as well.

Finding the right balance

There can often be a fine dividing line between spending too much on corporate gifting, or too little. Neither scenario is good, for many reasons.

If you try to cut corners and end up with something that looks too cheap, it sends out the wrong message about your business and the recipient won’t feel that valued either. On the other hand, if your gift is too extravagant, it can lead someone to think that you must be making too much money out of them to be able to afford to spend so lavishly.

Advertisement

As you can see, it’s a fine balancing act to get it just right. A good approach would be to look at branded gifts that are of a good quality but also serve a useful or practical purpose, which makes them more likely to be well received.

A good example of this would be if you gave someone a good quality branded coffee mug. They are likely to use it on a regular basis, so you get a positive brand association, and it won’t have blown a huge hole in your overall marketing budget.

All things considered, rather than simply focusing on price to decide how much you spend you should also consider how well your branded gift will be received by the person you give it to.

Advertisement

Continue Reading

Business

Earnings call transcript: First Western Financial beats Q1 2026 EPS estimates

Published

on


Earnings call transcript: First Western Financial beats Q1 2026 EPS estimates

Continue Reading

Business

The Procter & Gamble Company (PG) Q3 2026 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Conference Call Participants

Stephen Robert Powers – Deutsche Bank AG, Research Division
Dara Mohsenian – Morgan Stanley, Research Division
Lauren Lieberman – Barclays Bank PLC, Research Division
Peter Grom – UBS Investment Bank, Research Division
Peter Galbo – BofA Securities, Research Division
Christopher Carey – Wells Fargo Securities, LLC, Research Division
Robert Ottenstein – Evercore ISI Institutional Equities, Research Division
Kevin Grundy – BNP Paribas, Research Division
Filippo Falorni – Citigroup Inc., Research Division
Bonnie Herzog – Goldman Sachs Group, Inc., Research Division
Kaumil Gajrawala – Jefferies LLC, Research Division
Andrea Teixeira – JPMorgan Chase & Co, Research Division
Olivia Tong Cheang – Raymond James & Associates, Inc., Research Division
Robert Moskow – TD Cowen, Research Division
Edward Lewis – Rothschild & Co Redburn, Research Division
Michael Lavery – Piper Sandler & Co., Research Division

Presentation

Advertisement

Operator

Good morning, and welcome to Procter & Gamble’s quarter end conference call. Today’s event is being recorded for replay. This discussion will include a number of forward-looking statements.

If you will refer to P&G’s most recent 10-K, 10-Q and 8-K reports, you will see a discussion of factors that could cause the company’s actual results to differ materially from these projections.

As required by Regulation G, Procter & Gamble needs to make you aware that during the discussion, the company will make a number of references to non-GAAP and other financial measures. Procter & Gamble believes these measures provide investors with useful perspective on underlying business trends and has posted on its Investor Relations website, www.pginvestor.com, a full reconciliation of non-GAAP financial measures.

Advertisement

Now I will turn the call over to P&G’s Chief Financial Officer, Andre Schulten.

Andre Schulten
Chief Financial Officer

Good morning, everyone. Joining me on the call today are John Chevalier

Advertisement
Continue Reading

Business

Island's inflation rate is 2.7%, new figures show

Published

on

Island's inflation rate is 2.7%, new figures show

Statistics Jersey says there have been “sharp increases” in some energy prices.

Continue Reading

Business

AI Dominance Fuels Strong Buy Consensus Despite High Valuation

Published

on

Microsoft CEO Satya Nadella says the US tech giant plans to invest $3 billion in India on AI and cloud infrastructure over the next two years

SANTA CLARA, Calif. — Nvidia Corp. remains one of the most compelling yet polarizing investment stories in 2026, with Wall Street analysts overwhelmingly recommending investors buy shares of the AI chip leader even as the stock trades at elevated valuations following massive gains driven by insatiable demand for its GPUs.

Tech giants in the AI race have been spending billions of dollars for GPUs made by Nvidia, considered a leader when it comes to chips that power the technology
Nvidia Stock Buy or Sell in 2026: AI Dominance Fuels Strong Buy Consensus Despite High Valuation
AFP

As of late April 2026, Nvidia’s consensus rating stands as Strong Buy from dozens of analysts covering the stock. The average 12-month price target hovers around $268–$275, implying roughly 30–35% upside from recent trading levels near $200. Individual targets range from conservative lows near $210 to optimistic highs of $380, reflecting varying assumptions about the pace of AI infrastructure spending.

The bull case is straightforward and powerful. Nvidia continues to dominate the artificial intelligence accelerator market with its Blackwell and Hopper architectures. Data Center revenue has exploded, powering massive hyperscale buildouts by companies like Microsoft, Google, Meta and Amazon. Recent quarterly results showed revenue exceeding $68 billion in one period, with gross margins remaining exceptionally strong above 70%. Analysts project continued robust growth through 2027 as inference workloads and enterprise AI adoption accelerate.

CEO Jensen Huang has repeatedly emphasized that the company is still in the early innings of the AI revolution. New product cycles, including the Rubin architecture expected later in 2026, keep Nvidia firmly ahead of competitors. Partnerships, software moats through CUDA, and expanding total addressable market in robotics, autonomous vehicles and sovereign AI initiatives provide multiple growth vectors.

Several major banks and research firms have raised price targets in recent months. Rosenblatt, JPMorgan, Bank of America and others see significant upside, with some calling for $300+ by year-end. The consensus among more than 50 analysts shows overwhelming Buy or Strong Buy ratings, with very few Holds and almost no Sells.

Advertisement

Bears, however, highlight legitimate risks. Nvidia’s valuation — trading at premium forward multiples — leaves little room for disappointment. Competition from AMD, custom chips from hyperscalers, and potential margin pressure as the market matures could weigh on returns. Geopolitical tensions, export restrictions to China and any slowdown in Big Tech capital expenditure represent meaningful headwinds. Some analysts caution that expectations may already be too high.

For long-term growth investors, the case for buying Nvidia remains compelling. The company sits at the center of the most transformative technology shift since the internet. Strong balance sheet, exceptional execution under Huang, and a widening technological lead support continued outperformance. Many portfolio managers view it as a core holding for exposure to AI infrastructure.

Shorter-term traders or more conservative investors might exercise caution at current levels. Pullbacks on any perceived AI spending moderation could offer better entry points. Diversification is essential given the stock’s volatility and concentration risk in a single technology theme.

Institutional ownership remains very high, and retail enthusiasm continues. Options activity shows bullish sentiment overall, though elevated implied volatility reflects uncertainty around upcoming product cycles and macro factors. The stock has delivered extraordinary returns over the past several years, but past performance does not guarantee future results.

Advertisement

Nvidia’s trajectory in 2026 will likely be shaped by successful execution on next-generation platforms, sustained data center demand and the company’s ability to defend its massive market share. Positive developments on these fronts could drive shares significantly higher, while any stumbles might lead to sharp corrections typical of high-growth tech names.

Ultimately, whether to buy or sell Nvidia in 2026 depends heavily on individual risk tolerance, time horizon and conviction in the AI secular trend. Growth-oriented investors with a multi-year perspective generally see it as a Buy. Those seeking stability or concerned about valuations may prefer to Hold existing positions or wait for dips. Most advisors recommend sizing positions thoughtfully within a diversified portfolio.

As the AI supercycle continues unfolding, Nvidia stands as the clearest and most dominant beneficiary. With strong analyst support, robust fundamentals and multiple growth drivers, the company offers significant potential for patient investors — even after years of spectacular gains. The debate is not whether Nvidia will grow, but how much and at what valuation the market is willing to pay.

Advertisement
Continue Reading

Trending

Copyright © 2025